Analyst Ratings for NovaBay Pharmaceuticals (NBY)
NBY Rating Summary
NBY Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$9.50 (+11775%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Rating Score: 3.3 / 10
Percentile Rank: 30%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/18/2019 | Ladenburg Thalmann » Updated 3/26/2021 |
Jeffrey Cohen | New Coverage | Buy (N/A) |
1.90 (1.75) |
0.53 (0.08) |
-84.91% | Details |
| 3/13/2019 | Laidlaw » Updated 7/29/2019 |
Francois Brisebois | Downgrade | Hold (Buy) |
1.00 (0.75) |
1.50 (0.08) |
-94.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
